MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC).

Mehdi, M; Thalji, SZ; Shreenivas, AV; Chakrabarti, S; Thomas, JP; Christians, KK; Evans, DB; Hall, WA; Erickson, B; Thapa, B; Ahmed, G; Yazdanpanah, O; Kurzrock, R; Aldakkak, M; Holden, MB; Ben George; Tsai, S; Oxencis, C; McFall, T; Kamgar, M

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16): E16260

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索